Connection

Martin Bachmann to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Martin Bachmann has written about Drug Evaluation, Preclinical.
Martin Bachmann
Connection Strength
0.083
Drug Evaluation, Preclinical
  1. Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine. Front Immunol. 2019; 10:1015.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.